Forbes March 24, 2024
A new study that included 221,714 adults and adolescents with attention-deficit/hyperactivity disorder (ADHD) found that those who were prescribed ADHD stimulant medications were at a lower risk of attempting suicide or dying by suicide. Additionally, the use of ADHD medications was also associated with fewer psychiatric hospitalizations.
Heidi Taipale, a researcher at Karolinska Institute in Stockholm, Sweden, and colleagues, observed that four ADHD medications were linked to a decreased risk of being hospitalized due to psychiatric co-morbidities — amphetamine, lisdexamphetamine, dexamphetamine, and methylphenidate.
Whereas a decreased risk of suicidal behavior was only associated with using lisdexamphetamine, dexamphetamine, and methylphenidate. A 2019 study conducted in Sweden revealed that the prevalence of psychiatric co-morbidity was 52% among children and adults with ADHD....
Today's Sponsors
Today's Sponsor